top of page

MC38 Syngeneic Model

Rincon Bio offers efficacy studies using the MC38 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Colon
Derivation:
Primary colon adenocarcinoma in a C57BL/6 mouse
Mutations:
Unavailable
NCI60:
No
Weeks from stratification to termination (average):
4

MC38 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the MC38 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page